RA Capital Management

Activity in this selectionFeb 28, 2026 · Feb 1, 2026

By stage

Series A2

Series B1

Biotech2

Climate tech1

United States3

3 in this selection

Feb 24

Advancing next-generation therapeutics for migraine and other headache disorders

$130MSeries A

Role not disclosed

Feb 10

Developing a next-generation pertussis vaccine candidate BPZE1

$115MSeries B

Role not disclosed

Feb 3

Develops modular compact fusion machines for clean energy applications

$29MSeries A

Role not disclosed